FIELD: medicine.
SUBSTANCE: the present innovation deals with diagnostics in vitro hypertension diathesis caused with genetic factors due to detecting in a sample (a) SNP which should be detected in exon 8(C→T) of hsgk1 gene and presented in SEQ ID NO:1, and also (B) SNP which should be detected in intron 6(T→C) of hsgk1 gene and localized in a fragment of 551 size being opposite the transcription against SNP in exon 8 according to item (a), or both SNP according to items (a) and (b). The innovation refers, also, to application of such SNP for obtaining a diagnostic kits and sets for carrying out diagnostics of hypertension diathesis caused with genetic factors. The method provides concrete sequences of hsgk1 gene that cause hypertension diathesis.
EFFECT: higher accuracy and efficiency of diagnostic analysis.
3 cl, 2 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| sgk1 AS DIAGNOSTIC AND THERAPEUTIC TARGET | 2003 |
|
RU2331072C2 |
| KINASES sgk 2 AND sgk 3 AS THE TARGETS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES | 2001 |
|
RU2310471C2 |
| DRUGS CONTAINING HUMAN h-sgk KINASE INHIBITORS CONTROLLING CELL VOLUME | 2000 |
|
RU2288718C9 |
| METHOD FOR PREDICTION OF BLOOD PRESSURE LEVEL IN PREGNANT WOMEN DEPENDING ON GENETIC ENDOTHELIN 1 POLYMORPHISM | 2011 |
|
RU2473912C1 |
| GENETIC TEST FOR LIVER COPPER ACCUMULATION IN DOGS | 2012 |
|
RU2662660C2 |
| GENETIC TEST FOR COPPER ACCUMULATION IN LIVER IN DOGS | 2012 |
|
RU2707814C2 |
| MUTATIONS OF MTS GENE IN EMBRYONIC LINE AND METHOD OF DETECTION OF PREDISPOSITION TO MALIGNANT TUMORS | 1995 |
|
RU2161309C2 |
| MTS GENE, MUTATIONS OF THIS GENE AND METHODS OF DIAGNOSIS OF MALIGNANT TUMORS USING MTS GENE SEQUENCE | 1995 |
|
RU2164419C2 |
| METHOD OF FINDING PRONENESS TO HIGH-ALTITUDE PULMONARY EDEMA | 2003 |
|
RU2353656C2 |
| GENETIC TEST FOR COPPER ACCUMULATION IN LIVER IN DOGS | 2019 |
|
RU2746093C1 |
